17-Hydroxy Progesterone (OHP) at Lahore PCR Lab

Introduction to 17-Hydroxy Progesterone (OHP) Testing

The 17-Hydroxy Progesterone (OHP) test is a highly specialized endocrine investigation used to measure the concentration of 17-OHP in the blood. 17-Hydroxyprogesterone is an endogenous steroid hormone produced during the synthesis of cortisol. This metabolic pathway takes place within the adrenal cortex, where cholesterol is sequentially converted into various steroid hormones. When there is an enzymatic deficiency in this pathway—most commonly a deficiency of the 21-hydroxylase enzyme—17-OHP cannot be efficiently converted into cortisol. Consequently, 17-OHP accumulates in the bloodstream, while cortisol levels remain low. This biochemical imbalance is the hallmark of Congenital Adrenal Hyperplasia (CAH), a group of inherited autosomal recessive disorders. At Lahore PCR Lab in Lahore, Pakistan, this test is performed using state-of-the-art automated immunoassay analyzers, ensuring clinical precision and rapid turnaround times for patients and referring physicians.

Understanding the diagnostic value of 17-OHP is crucial for managing endocrine disorders. The adrenal glands, located superior to the kidneys, are responsible for producing vital hormones including cortisol (which regulates metabolism, blood pressure, and stress responses), aldosterone (which maintains salt and water balance), and androgens (male sex hormones). When 17-OHP builds up due to an enzymatic block, the excess precursor is shunted into the androgen synthesis pathway, leading to an overproduction of male hormones. This can cause severe physical symptoms depending on the patient’s age and biological sex. By measuring 17-OHP levels, endocrinologists, pediatricians, and gynecologists can accurately diagnose CAH, evaluate cases of ambiguous genitalia in newborns, investigate hirsutism and virilization in females, and monitor the efficacy of hormone replacement therapy. Lahore PCR Lab provides a reliable diagnostic environment, utilizing advanced chemiluminescent microparticle immunoassay (CMIA) or enzyme-linked immunosorbent assay (ELISA) technologies to deliver highly sensitive and specific quantitative measurements.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest degree of accuracy and to minimize physiological variations, patients must adhere to specific preparation guidelines prior to undergoing the 17-Hydroxy Progesterone (OHP) test at Lahore PCR Lab:

• Diurnal Variation and Timing: 17-OHP levels exhibit a diurnal rhythm similar to cortisol, peaking in the early morning hours. Therefore, it is highly recommended that the blood sample be collected between 7:00 AM and 9:00 AM.
• Menstrual Cycle Timing: For menstruating females, the timing of the test is critical because 17-OHP levels fluctuate during the menstrual cycle. The sample should ideally be collected during the early follicular phase (usually days 1 to 5 of the menstrual cycle) unless otherwise directed by the physician.
• Fasting Requirements: While strict fasting is not universally mandatory, a fasting period of 8 to 12 hours is often preferred to prevent potential dietary interference with lipid-based hormone assays. Patients may drink plain water during this period.
• Medication Disclosure: Patients must inform the laboratory staff and their referring physician about all medications they are currently taking, particularly topical, oral, or inhaled corticosteroids (such as hydrocortisone, prednisone, or dexamethasone), oral contraceptive pills, and progesterone supplements, as these can significantly alter test results.
• Stress Management: Physical and emotional stress can stimulate the adrenal glands and falsely elevate 17-OHP levels. Patients should rest quietly for 15 to 20 minutes before the blood draw.

During the Procedure

The 17-Hydroxy Progesterone (OHP) test is a standard venipuncture procedure performed by experienced phlebotomists at Lahore PCR Lab. The patient is comfortably seated, and the phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa of the arm. The skin over the selected vein is thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) to prevent contamination. A sterile, single-use needle is inserted into the vein, and blood is drawn into a serum separator tube (SST) or a plain red-top tube. Once the required volume of blood (typically 3 to 5 milliliters) is collected, the needle is gently withdrawn, and local pressure is applied to the puncture site with a sterile cotton swab to promote hemostasis. A band-aid or sterile dressing is then applied. The entire collection process takes less than five minutes and involves minimal discomfort, comparable to a mild pinch. The collected blood sample is allowed to clot, centrifuged to separate the serum, and promptly processed in the biochemistry division of Lahore PCR Lab under strict quality control protocols.

When is a 17-Hydroxy Progesterone (OHP) Test Performed?

Screening for Congenital Adrenal Hyperplasia (CAH) in Newborns

The primary clinical indication for the 17-OHP test is screening for Congenital Adrenal Hyperplasia (CAH) in neonates. Classical CAH is a life-threatening condition that manifests shortly after birth. Newborns with the salt-wasting form of CAH cannot produce aldosterone, leading to severe hyponatremia, hyperkalemia, dehydration, and cardiovascular collapse (adrenal crisis). Pediatricians request this test immediately if a newborn exhibits poor feeding, vomiting, failure to thrive, or ambiguous genitalia. Early detection through 17-OHP measurement at Lahore PCR Lab allows for prompt initiation of life-saving glucocorticoid and mineralocorticoid replacement therapy, preventing severe morbidity and mortality.

Evaluating Hirsutism and Virilization in Females

In adolescent girls and adult women, physicians order a 17-OHP test to investigate symptoms of androgen excess, such as hirsutism (excessive male-pattern hair growth on the face, chest, and back), severe treatment-resistant acne, male-pattern baldness (androgenic alopecia), and virilization (deepening of the voice, clitoromegaly, and increased muscle mass). These symptoms often stem from non-classical Congenital Adrenal Hyperplasia (NCAH), a milder, late-onset form of the enzyme deficiency. Measuring 17-OHP helps clinicians differentiate NCAH from other causes of hyperandrogenism, such as ovarian tumors or Cushing’s syndrome, guiding appropriate therapeutic interventions.

Investigating Menstrual Irregularities and Polycystic Ovary Syndrome (PCOS)

Menstrual abnormalities, including oligomenorrhea (infrequent periods) and amenorrhea (absence of periods), are common clinical presentations in reproductive-aged women. Because the clinical features of non-classical CAH closely mimic those of Polycystic Ovary Syndrome (PCOS), gynecologists and endocrinologists routinely include the 17-OHP test in the diagnostic workup of suspected PCOS. Distinguishing between these two conditions is vital because their long-term management strategies, genetic counseling implications, and fertility treatments differ significantly. Lahore PCR Lab provides precise hormone profiling to assist clinicians in making this critical distinction.

Assessing Precocious Puberty in Children

Precocious puberty refers to the abnormally early onset of secondary sexual characteristics (before age 8 in girls and age 9 in boys). Children with late-onset CAH may experience rapid growth spurts, early development of pubic and axillary hair, advanced bone age, and early fusion of growth plates, leading to short adult stature. Pediatric endocrinologists utilize the 17-OHP test to evaluate the hypothalamic-pituitary-adrenal axis and identify whether premature adrenal activation (premature adrenarche) or an underlying enzymatic block in the adrenal pathway is responsible for the early pubertal development.

Monitoring CAH Treatment and Adrenal Enzyme Deficiencies

For patients already diagnosed with Congenital Adrenal Hyperplasia, the 17-OHP test is an indispensable tool for monitoring the adequacy of glucocorticoid replacement therapy. The therapeutic goal is to supply sufficient glucocorticoids to suppress the oversecretion of adrenocorticotropic hormone (ACTH) by the pituitary gland, thereby reducing the drive on the adrenal glands and lowering 17-OHP and androgens. Regular monitoring at Lahore PCR Lab helps endocrinologists fine-tune medication dosages, striking a delicate balance between under-treatment (which leads to virilization and rapid bone maturation) and over-treatment (which causes Cushingoid side effects and growth suppression).

What Does a 17-Hydroxy Progesterone (OHP) Test Detect?

The 17-Hydroxy Progesterone (OHP) test is highly sensitive and capable of detecting a wide range of biochemical alterations and clinical conditions related to adrenal steroidogenesis. Specifically, the test detects and assists in the evaluation of:

• Classical 21-hydroxylase deficiency (salt-wasting form) in neonates
• Classical 21-hydroxylase deficiency (simple virilizing form)
• Non-classical (late-onset) 21-hydroxylase deficiency in adolescents and adults
• Carrier status for 21-hydroxylase deficiency (when combined with ACTH stimulation testing)
• Adrenal cortical hyperplasia (bilateral enlargement of the adrenal glands)
• Adrenal tumors (both benign adenomas and malignant carcinomas that secrete steroid precursors)
• Ovarian tumors or luteoma of pregnancy (which can occasionally secrete progesterone derivatives)
• Hypocortisolemia (low cortisol production resulting from enzymatic blocks)
• Hypoaldosteronism (leading to electrolyte imbalances like low sodium and high potassium)
• Androgen excess states resulting from metabolic shunting
• Precocious adrenarche (premature activation of adrenal androgen secretion)
• Efficacy of glucocorticoid replacement therapy (hydrocortisone, prednisone, or dexamethasone)
• Compliance with prescribed hormonal treatment regimens
• Adrenal insufficiency secondary to enzyme pathway mutations
• Hypothalamic-pituitary-adrenal (HPA) axis suppression or dysregulation
• Ovarian hyperandrogenism (by ruling out adrenal sources of excess androgens)
• Enzymatic blocks associated with 11-beta-hydroxylase deficiency (where 17-OHP may be moderately elevated)
• Enzymatic blocks associated with 3-beta-hydroxysteroid dehydrogenase deficiency
• Congenital adrenal hyperplasia-related infertility in both males and females
• Risk of adrenal crisis in high-risk pediatric patients

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely diagnostic insights are critical for effective patient management, especially when dealing with newborn screenings or complex endocrine evaluations. The turnaround time for the 17-Hydroxy Progesterone (OHP) test is typically within 24 to 48 hours from the time of sample collection. This rapid processing is made possible by our advanced, fully automated immunoassay platforms and optimized laboratory workflows. Once the analysis is complete, the results undergo a rigorous multi-tier verification process by our qualified clinical biochemists and consultant pathologists to ensure absolute accuracy.

Patients and referring physicians can access test reports conveniently through multiple channels. Lahore PCR Lab offers an online report download facility via our secure web portal, where patients can log in using their unique lab ID and password provided on the registration slip. Additionally, patients receive an automated SMS notification with a direct link to download their report as soon as it is finalized. For those who prefer physical copies, reports can be collected directly from our main facility in Lahore or any of our designated collection centers. Our reports feature clear reference ranges categorized by age, sex, and menstrual phase, enabling clinicians to make immediate and well-informed clinical decisions.

17-Hydroxy Progesterone (OHP) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Newborns (3 days or older)	Less than 2.0 ng/mL (highly dependent on gestational age and birth weight)	Markedly elevated (often greater than 10.0 to 100.0 ng/mL) indicating Classical Congenital Adrenal Hyperplasia (CAH).
Adult Males	0.5 to 2.0 ng/mL	Elevated levels may suggest late-onset CAH, adrenal tumors, or testicular adrenal rest tumors (TARTs).
Adult Females (Follicular Phase)	0.2 to 1.0 ng/mL	Elevated levels (typically 2.0 to 10.0 ng/mL) suggest Non-Classical Congenital Adrenal Hyperplasia (NCAH) or PCOS.
Adult Females (Luteal Phase)	1.0 to 4.0 ng/mL (physiological rise due to corpus luteum progesterone production)	Significantly elevated levels exceeding luteal reference ranges may indicate adrenal pathology or NCAH.
Postmenopausal Females	Less than 0.5 ng/mL	Elevated levels point toward adrenal tumors, late-onset CAH, or exogenous hormone interference.
ACTH Stimulation Test (Post-Stimulation)	Less than 2.0 to 5.0 ng/mL	Exaggerated response (greater than 10.0 ng/mL) confirms carrier status or non-classical CAH.
CAH Treatment Monitoring	Maintained within a target therapeutic range (typically slightly above normal to avoid over-suppression)	Extremely high levels indicate under-treatment or non-compliance; extremely low levels indicate over-treatment with glucocorticoids.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for 17-Hydroxy Progesterone (OHP)?

• Experienced healthcare professionals: Our team consists of highly qualified consultant pathologists, clinical biochemists, and skilled phlebotomists dedicated to maintaining the highest standards of diagnostic medicine.
• Patient-focused care: We prioritize patient comfort, safety, and confidentiality at every stage of the diagnostic journey, ensuring a compassionate and supportive environment.
• Quality diagnostic services: Lahore PCR Lab implements stringent internal quality control measures and participates in external quality assurance programs to deliver highly reliable and reproducible test results.
• Professional reporting: Our diagnostic reports are comprehensive, featuring detailed, age- and sex-specific reference intervals that facilitate precise clinical interpretation by endocrinologists.
• Modern diagnostic approach: We utilize advanced automated immunoassay platforms and state-of-the-art laboratory equipment to minimize human error and maximize analytical sensitivity.
• Comfortable environment: Our main facility and collection centers in Lahore are designed to provide a clean, hygienic, and stress-free environment for patients of all ages, including infants and children.
• Convenient location: Strategically located in Lahore, Pakistan, our laboratory is easily accessible, offering ample parking and convenient operating hours to accommodate busy schedules.
• Commitment to accurate diagnosis: We are dedicated to providing precise hormonal assays that serve as a cornerstone for the diagnosis and management of complex endocrine and genetic disorders.